drug

April 1, 2017 // 0 Comments

By American Kratom Association, Washington, DC, Special for USDR Even though the case for banning or scheduling kratom [...]

March 3, 2017 // 0 Comments

By PCMA, Special for USDR As part of its DrugBenefitSolutions.com campaign, the Pharmaceutical Care Management [...]

March 1, 2017 // 0 Comments

By Express Scripts, Special for USDR Express Scripts’ (NASDAQ: ESRX) efforts to put medicine within reach for [...]

By Beer Institute, Special for USDR According to the University of Michigan’s Monitoring the Future analysis of [...]

By Robert Weiner Associates, Special for USDR The resurgence of cocaine from Colombia, the U.S. and world’s number [...]

By Pharmaceutical Research and Manufacturers of America, Special for USDR Despite recent headlines, U.S. spending on [...]

By The Partnership for Drug-Free Kids, Special for USDR The Partnership for Drug-Free Kids (“Partnership”), a [...]

By American Kratom Association; Botanical Education Alliance, Washington, D.C. Two letters from a bipartisan group of 11 [...]

By Foundation for a Drug-Free World, Special for USDR Volunteers are making a difference in Rio—they have distributed a [...]

By Urban Drug Policies Conference, Special for USDR From 17 to 19 February 2016, a group of international experts on [...]

July 22, 2015 // 0 Comments

By Frank J. Granett R.ph. Nationally regarded civil rights attorney, Allison Folmar from Detroit, Michigan advises parents [...]

June 9, 2015 // 0 Comments

By NCPA, Special for USDR Alabama legislators could save taxpayers millions with a few simple changes to the way Medicaid [...]

By NCPA, Special for USDR Increasing unnecessary regulations on drug plans could inflict higher costs on the 220 million [...]

May 1, 2014 // 0 Comments

By USDR Health policy experts with the National Center for Public Policy Research today questioned the CEOs of two of the [...]